Morgan Stanley’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.6M Sell
1,346,206
-8,017
-0.6% -$151K ﹤0.01% 2843
2025
Q4
$25.9M Sell
1,354,223
-27,139
-2% -$498K ﹤0.01% 2691
2025
Q3
$23.9M Sell
1,381,362
-57,717
-4% -$983K ﹤0.01% 2719
2025
Q2
$26.5M Sell
1,439,079
-29,162
-2% -$542K ﹤0.01% 2531
2025
Q1
$30.3M Buy
1,468,241
+22,847
+2% +$467K ﹤0.01% 2280
2024
Q4
$27.3M Sell
1,445,394
-11,720
-0.8% -$242K ﹤0.01% 2450
2024
Q3
$32.2M Sell
1,457,114
-22,571
-2% -$483K ﹤0.01% 2301
2024
Q2
$30.2M Sell
1,479,685
-20,242
-1% -$402K ﹤0.01% 2223
2024
Q1
$30.1M Sell
1,499,927
-1,395,023
-48% -$26.8M ﹤0.01% 2240
2023
Q4
$52.4M Buy
2,894,950
+1,298,325
+81% +$22M ﹤0.01% 2398
2023
Q3
$27.1M Buy
1,596,625
+1,297
+0.1% +$24.1K ﹤0.01% 2139
2023
Q2
$30.4M Sell
1,595,328
-40,003
-2% -$754K ﹤0.01% 2047
2023
Q1
$30.7M Sell
1,635,331
-53,795
-3% -$1.03M ﹤0.01% 1983
2022
Q4
$33.5M Buy
1,689,126
+33,667
+2% +$664K ﹤0.01% 1856
2022
Q3
$30M Buy
1,655,459
+55,415
+3% +$1.11M ﹤0.01% 1772
2022
Q2
$31.9M Sell
1,600,044
-265,651
-14% -$5.56M ﹤0.01% 1777
2022
Q1
$41.5M Buy
1,865,695
+17,443
+0.9% +$390K 0.01% 1437
2021
Q4
$47.4M Sell
1,848,252
-247,241
-12% -$5.94M 0.01% 1375
2021
Q3
$47.5M Buy
2,095,493
+99,938
+5% +$2.41M 0.01% 1329
2021
Q2
$46.1M Buy
1,995,555
+200,066
+11% +$4.59M 0.01% 1371
2021
Q1
$39M Buy
1,795,489
+78,749
+5% +$1.65M 0.01% 1360
2020
Q4
$35M Buy
1,716,740
+11,753
+0.7% +$225K 0.01% 1362
2020
Q3
$30.8M Buy
1,704,987
+86,042
+5% +$1.56M 0.01% 1173
2020
Q2
$28.8M Buy
1,618,945
+111,249
+7% +$1.96M 0.01% 1168
2020
Q1
$23.2M Buy
1,507,696
+68,712
+5% +$1.21M 0.01% 1181
2019
Q4
$27.4M Buy
1,438,984
+120,043
+9% +$2.17M 0.01% 1380
2019
Q3
$23M Sell
1,318,941
-36,398
-3% -$638K 0.01% 1384
2019
Q2
$24.2M Sell
1,355,339
-170,690
-11% -$2.93M 0.01% 1344
2019
Q1
$26.9M Sell
1,526,029
-359,629
-19% -$6.27M 0.01% 1234
2018
Q4
$31.6M Sell
1,885,658
-18,260
-1% -$324K 0.01% 1093
2018
Q3
$35.7M Sell
1,903,918
-2,268
-0.1% -$41.1K 0.01% 1190
2018
Q2
$32.5M Sell
1,906,186
-34,316
-2% -$576K 0.01% 1195
2018
Q1
$32M Sell
1,940,502
-3,430
-0.2% -$59.9K 0.01% 1249
2017
Q4
$34.1M Sell
1,943,932
-85,863
-4% -$1.53M 0.01% 1229
2017
Q3
$37.7M Sell
2,029,795
-81,938
-4% -$1.5M 0.01% 1090
2017
Q2
$38.7M Buy
2,111,733
+3,616
+0.2% +$63.5K 0.01% 1051
2017
Q1
$36.7M Buy
2,108,117
+139,503
+7% +$2.38M 0.01% 1103
2016
Q4
$30.6M Buy
1,968,614
+8,863
+0.5% +$144K 0.01% 1187
2016
Q3
$34.3M Buy
1,959,751
+145,999
+8% +$2.54M 0.01% 1075
2016
Q2
$30.2M Buy
1,813,752
+40,927
+2% +$668K 0.01% 1113
2016
Q1
$28.2M Sell
1,772,825
-141,432
-7% -$2.19M 0.01% 1102
2015
Q4
$33.3M Sell
1,914,257
-112,241
-6% -$1.93M 0.01% 1057
2015
Q3
$33M Sell
2,026,498
-50,849
-2% -$974K 0.01% 1038
2015
Q2
$41.2M Buy
2,077,347
+172,200
+9% +$3.53M 0.01% 978
2015
Q1
$39.2M Buy
1,905,147
+279,087
+17% +$5.63M 0.01% 993
2014
Q4
$32.6M Buy
1,626,060
+876,063
+117% +$17M 0.01% 1110
2014
Q3
$14.1M Buy
+749,997
New +$15M 0.01% 1718

Other funds holding THQ

Morgan Stanley's THQ Position: Q1 2026 in Review

Morgan Stanley reduced its abrdn Healthcare Opportunities Fund (THQ) stake by 0.59% in Q1 2026, selling an estimated $151K and leaving 1,346,206 shares worth $22.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2843.

Morgan Stanley first reported a position in THQ in Q3 2014 and has held it in 47 quarters since. The position peaked at $52.4M in Q4 2023. 88 funds tracked by Wall St. Rank hold THQ as of Q1 2026.

  • Morgan Stanley held 1,346,206 shares of abrdn Healthcare Opportunities Fund worth $22.6M as of Q1 2026.
  • Morgan Stanley sold 8,017 abrdn Healthcare Opportunities Fund shares in Q1 2026, an estimated $151K.
  • abrdn Healthcare Opportunities Fund made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2843 holding.
  • Morgan Stanley first reported a position in abrdn Healthcare Opportunities Fund in Q3 2014 and has held it in 47 quarters since.
  • Morgan Stanley's abrdn Healthcare Opportunities Fund position peaked at $52.4M in Q4 2023.
  • 88 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.